CureVac N.V. EBITDA for the year ending December 31, 2024:
USD 217.13 M
CureVac N.V. EBITDA is USD 217.13 M for the year ending December 31, 2024, a -184.04% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
-
CureVac N.V. EBITDA for the year ending December 31, 2023 was USD -258.38 M, a 15.33% change year over year.
-
CureVac N.V. EBITDA for the year ending December 31, 2022 was USD -224.03 M, a -49.08% change year over year.
-
CureVac N.V. EBITDA for the year ending December 31, 2021 was USD -439.96 M, a 192.58% change year over year.
-
CureVac N.V. EBITDA for the year ending December 31, 2020 was USD -150.37 M, a 46.44% change year over year.